The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers

Mast cells (MCs) play important roles in normal immune responses and pathological states. The location of MCs on the boundaries between tissues and the external environment, including gut mucosal surfaces, lungs, skin, and around blood vessels, suggests a multitude of immunological functions. Thus, MCs are pivotal for host defense against different antigens, including allergens and microbial pathogens. MCs can produce and respond to physiological mediators and chemokines to modulate inflammation. As long-lived, tissue-resident cells, MCs indeed mediate acute inflammatory responses such as those evident in allergic reactions. Furthermore, MCs participate in innate and adaptive immune responses to bacteria, viruses, fungi, and parasites. The control of MC activation or stabilization is a powerful tool in regulating tissue homeostasis and pathogen clearance. Moreover, MCs contribute to maintaining the homeostatic equilibrium between host and resident microbiota, and they engage in crosstalk between the resident and recruited hematopoietic cells. In this review, we provide a comprehensive overview of the functions of MCs in health and disease. Further, we discuss how mouse models of MC deficiency have become useful tools for establishing MCs as a potential cellular target for treating inflammatory disorders.

[1]  R. Bellomo,et al.  Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra , 2021, International journal of molecular sciences.

[2]  C. González-Espinosa,et al.  Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles , 2021, Frontiers in Immunology.

[3]  S. Reddy,et al.  Mast Cells: A New Frontier for Cancer Immunotherapy , 2021, Cells.

[4]  J. Dastych,et al.  The Art of Mast Cell Adhesion , 2020, Cells.

[5]  B. Gartrell,et al.  Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. , 2020, Kidney international.

[6]  A. Jimeno,et al.  Avapritinib for metastatic or unresectable gastrointestinal stromal tumors. , 2020, Drugs of today.

[7]  R. Hass Role of MSC in the Tumor Microenvironment , 2020, Cancers.

[8]  J. Timmermans,et al.  MRGPRX2 and Immediate Drug Hypersensitivity: Insights from Cultured Human Mast Cells. , 2020, Journal of investigational allergology & clinical immunology.

[9]  M. Ernst,et al.  IL33 and Mast Cells—The Key Regulators of Immune Responses in Gastrointestinal Cancers? , 2020, Frontiers in Immunology.

[10]  P. Conti,et al.  Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37 , 2020, International journal of molecular sciences.

[11]  S. Meri,et al.  Mast cells and complement system: Ancient interactions between components of innate immunity , 2020, Allergy.

[12]  J. Bi,et al.  IL-37 is protective in allergic contact dermatitis through mast cell inhibition. , 2020, International immunopharmacology.

[13]  S. Frischbutter,et al.  Skin Mast Cells Contribute to Sporothrix schenckii Infection , 2020, Frontiers in Immunology.

[14]  Sohita Dhillon Avapritinib: First Approval , 2020, Drugs.

[15]  S. Martinotti,et al.  Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37. , 2020, European journal of pharmacology.

[16]  Mark G. Papich Masitinib Mesylate , 2020, Papich Handbook of Veterinary Drugs.

[17]  N. Pullen,et al.  Beyond IgE: Alternative Mast Cell Activation Across Different Disease States , 2020, International journal of molecular sciences.

[18]  L. Bielory,et al.  Mast Cell Biology at Molecular Level: a Comprehensive Review , 2019, Clinical Reviews in Allergy & Immunology.

[19]  J. Ritchey,et al.  Human Mast Cell Development from Hematopoietic Stem Cells in a Connective Tissue-Equivalent Model. , 2019, Tissue engineering. Part A.

[20]  R. Jessberger,et al.  Regulation of the pleiotropic effects of tissue-resident mast cells. , 2019, The Journal of allergy and clinical immunology.

[21]  C. Taube,et al.  Mast cells drive IgE-mediated disease but may be bystanders in many other inflammatory and neoplastic conditions. , 2019, The Journal of allergy and clinical immunology.

[22]  S. Galli,et al.  Mast cells are critical for controlling the bacterial burden and the healing of infected wounds , 2019, Proceedings of the National Academy of Sciences.

[23]  Yongfei Wang,et al.  Activation of Mast Cells Promote Plasmodium berghei ANKA Infection in Murine Model , 2019, Front. Cell. Infect. Microbiol..

[24]  C. Sommerhoff,et al.  Exosome-mediated uptake of mast cell tryptase into the nucleus of melanoma cells: a novel axis for regulating tumor cell proliferation and gene expression , 2019, Cell Death & Disease.

[25]  J. Marshall,et al.  Mast Cell Responses to Viruses and Pathogen Products , 2019, International journal of molecular sciences.

[26]  F. Redegeld,et al.  Role of Mast Cells in Shaping the Tumor Microenvironment , 2019, Clinical Reviews in Allergy & Immunology.

[27]  M. Hibbs,et al.  IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization , 2019, Nature Communications.

[28]  A. Piliponsky,et al.  Mast Cells in Viral, Bacterial, and Fungal Infection Immunity , 2019, International journal of molecular sciences.

[29]  E. Mendez-Enriquez,et al.  Mast Cells and Their Progenitors in Allergic Asthma , 2019, Front. Immunol..

[30]  F. Granata,et al.  Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019 , 2019, International Archives of Allergy and Immunology.

[31]  Shravan Morla Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation , 2019, International journal of molecular sciences.

[32]  P. Conti,et al.  Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. , 2019, Journal of biological regulators and homeostatic agents.

[33]  T. Sumpter,et al.  Cutaneous immune responses mediated by dendritic cells and mast cells. , 2019, JCI insight.

[34]  C. Pucillo,et al.  Mast Cells Respond to Candida albicans Infections and Modulate Macrophages Phagocytosis of the Fungus , 2018, Front. Immunol..

[35]  E. Sztul,et al.  Role of Host Cell Secretory Machinery in Zika Virus Life Cycle , 2018, Viruses.

[36]  L. Bjermer,et al.  Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2 , 2018, Cell Communication and Signaling.

[37]  C. Mathias,et al.  The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets , 2018, Front. Immunol..

[38]  M. Simon,et al.  Genetic and metabolic hallmarks of clear cell renal cell carcinoma. , 2018, Biochimica et biophysica acta. Reviews on cancer.

[39]  J. Renauld,et al.  IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut , 2018, Cell reports.

[40]  Di Zhang,et al.  Critical roles of TRPV2 channels, histamine H1 and adenosine A1 receptors in the initiation of acupoint signals for acupuncture analgesia , 2018, Scientific Reports.

[41]  M. Harnett,et al.  IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62 , 2018, Scientific Reports.

[42]  M. Tsai,et al.  Mast cells as sources of cytokines, chemokines, and growth factors , 2018, Immunological reviews.

[43]  F. Redegeld,et al.  Non‐IgE mediated mast cell activation , 2018, Immunological reviews.

[44]  E. Fuentes-Pananá,et al.  Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer , 2018, Journal of immunology research.

[45]  F. Redegeld,et al.  Mast Cells as Drivers of Disease and Therapeutic Targets. , 2017, Trends in immunology.

[46]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[47]  M. Colombo,et al.  Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses. , 2017, Trends in immunology.

[48]  F. Levi-Schaffer,et al.  Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer , 2017, Front. Med..

[49]  Zuojiong Gong,et al.  HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs , 2017, Oncology letters.

[50]  S. Deb,et al.  Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy? , 2017, Journal of Cancer Research and Clinical Oncology.

[51]  Irina Leonardi,et al.  Fungal dysbiosis: immunity and interactions at mucosal barriers , 2017, Nature Reviews Immunology.

[52]  K. Kullander,et al.  SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivo , 2017, Scientific Reports.

[53]  F. Granata,et al.  Are Mast Cells MASTers in Cancer? , 2017, Front. Immunol..

[54]  Yi Yao,et al.  SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway , 2017, International journal of oncology.

[55]  J. Renauld,et al.  A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis , 2017, Nature Communications.

[56]  S. Shibata,et al.  Regulation of plasma histamine levels by the mast cell clock and its modulation by stress , 2017, Scientific Reports.

[57]  A. Kadi,et al.  Identification and characterization of in vitro phase I and reactive metabolites of masitinib using a LC-MS/MS method: bioactivation pathway elucidation , 2017 .

[58]  M. Maurer,et al.  Mast Cells Limit the Exacerbation of Chronic Allergic Contact Dermatitis in Response to Repeated Allergen Exposure , 2016, The Journal of Immunology.

[59]  V. Barresi,et al.  Mast Cell Interaction with Neutrophils in Human Gastric Carcinomas: Ultrastructural Observations , 2016, Analytical cellular pathology.

[60]  M. Triggiani,et al.  Mast cells as effector cells of innate immunity and regulators of adaptive immunity. , 2016, Immunology letters.

[61]  E. Russo,et al.  Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment. , 2016, Cancer letters.

[62]  N. Shenoy,et al.  Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[63]  M. Saleem,et al.  Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells , 2016, Drug design, development and therapy.

[64]  D. Voehringer,et al.  Mucosal mast cells are indispensable for the timely termination of Strongyloides ratti infection , 2016, Mucosal Immunology.

[65]  F. Awan,et al.  Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis. , 2016, The New England journal of medicine.

[66]  D. Metcalfe,et al.  IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3. , 2016, The Journal of allergy and clinical immunology.

[67]  E. Giovannetti,et al.  Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective , 2016, Cancer Chemotherapy and Pharmacology.

[68]  Ailin Tao,et al.  Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment , 2016, Toxins.

[69]  F. Cunha,et al.  Mast cells phagocyte Candida albicans and produce nitric oxide by mechanisms involving TLR2 and Dectin-1. , 2016, Immunobiology.

[70]  J. Landsberg,et al.  A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells. , 2016, Cancer research.

[71]  J. Wood,et al.  Mast Cell: A Multi-Functional Master Cell , 2016, Front. Immunol..

[72]  H. Raifer,et al.  Mast cells have no impact on cutaneous leishmaniasis severity and related Th2 differentiation in resistant and susceptible mice , 2016, European journal of immunology.

[73]  R. Sironen,et al.  Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma , 2015, Melanoma research.

[74]  M. Colombo,et al.  The Role of Mast Cells in Molding the Tumor Microenvironment , 2015, Cancer Microenvironment.

[75]  I. Estrada-García,et al.  Recognition of Candida albicans by Dectin-1 induces mast cell activation. , 2015, Immunobiology.

[76]  Linda A. Lindsay Type I Hypersensitivity Reaction , 2015 .

[77]  L. Marti,et al.  Chemokines and immunity , 2015, Einstein.

[78]  G. Marone,et al.  Tumor-Associated Mast Cells in Thyroid Cancer , 2015, International journal of endocrinology.

[79]  S. Bulfone-Paus,et al.  Mast Cells as Regulators of T Cell Responses , 2015, Front. Immunol..

[80]  G. Nilsson,et al.  Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells , 2015, Scientific Reports.

[81]  H. Kiyono,et al.  Pathophysiological Role of Extracellular Purinergic Mediators in the Control of Intestinal Inflammation , 2015, Mediators of inflammation.

[82]  Joakim S. Dahlin,et al.  Distinguishing Mast Cell Progenitors from Mature Mast Cells in Mice , 2015, Stem cells and development.

[83]  I. Moura,et al.  The role of mast cells in cancers , 2015, F1000prime reports.

[84]  S. Thomsen Epidemiology and natural history of atopic diseases , 2015, European clinical respiratory journal.

[85]  T. Moon,et al.  Mast Cell Mediators: Their Differential Release and the Secretory Pathways Involved , 2014, Front. Immunol..

[86]  J. Davoust,et al.  Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis. , 2014, The Journal of clinical investigation.

[87]  Sakuo Yamada,et al.  Does β-Hexosaminidase Function Only as a Degranulation Indicator in Mast Cells? The Primary Role of β-Hexosaminidase in Mast Cell Granules , 2014, The Journal of Immunology.

[88]  Cheng Huang,et al.  Lipopolysaccharide/adenosine triphosphate induces IL‑1β and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells. , 2014, International journal of molecular medicine.

[89]  J. Brugarolas Molecular genetics of clear-cell renal cell carcinoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  G. Pejler,et al.  Mast cell secretory granules: armed for battle , 2014, Nature Reviews Immunology.

[91]  M. Maurer,et al.  Mast cells protect from skin tumor development and limit tumor growth during cutaneous de novo carcinogenesis in a Kit‐dependent mouse model , 2014, Experimental dermatology.

[92]  G. Newton,et al.  Leukocyte recruitment in inflammation: basic concepts and new mechanistic insights based on new models and microscopic imaging technologies , 2014, Cell and Tissue Research.

[93]  G. Stefanzl,et al.  The pan‐Bcl‐2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells , 2014, Journal of leukocyte biology.

[94]  C. Parish,et al.  Heparan Sulfate: A Ubiquitous Glycosaminoglycan with Multiple Roles in Immunity , 2013, Front. Immunol..

[95]  G. Sammarco,et al.  Mast Cells Positive to Tryptase and c-Kit Receptor Expressing Cells Correlates with Angiogenesis in Gastric Cancer Patients Surgically Treated , 2013, Gastroenterology research and practice.

[96]  Stephen J Galli,et al.  Mast Cells: Potential Positive and Negative Roles in Tumor Biology , 2013, Cancer Immunology Research.

[97]  T. Wilgus,et al.  Mast cell activity in the healing wound: more than meets the eye? , 2013, Experimental dermatology.

[98]  R. Hwang,et al.  Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. , 2013, Cancer research.

[99]  L. Kjellén,et al.  Pathophysiology of heparan sulphate: many diseases, few drugs , 2013, Journal of internal medicine.

[100]  D. Ribatti Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis. , 2013, Immunology letters.

[101]  Trees Jansen,et al.  Candida albicans Primes TLR Cytokine Responses through a Dectin-1/Raf-1–Mediated Pathway , 2013, The Journal of Immunology.

[102]  D. Voehringer Protective and pathological roles of mast cells and basophils , 2013, Nature Reviews Immunology.

[103]  T. Standiford,et al.  Bruton's tyrosine kinase mediates FcγRIIa/Toll-like receptor-4 receptor crosstalk in human neutrophils. , 2013, American journal of respiratory cell and molecular biology.

[104]  T. Moon,et al.  Limited replication of influenza A virus in human mast cells , 2012, Immunologic Research.

[105]  F. Liew,et al.  Interleukin-33 and the function of innate lymphoid cells. , 2012, Trends in immunology.

[106]  H. Rodewald,et al.  Widespread immunological functions of mast cells: fact or fiction? , 2012, Immunity.

[107]  D. Conrad,et al.  Cutting Edge: Mast Cells Critically Augment Myeloid-Derived Suppressor Cell Activity , 2012, The Journal of Immunology.

[108]  C. Pucillo,et al.  Mast Cell: An Emerging Partner in Immune Interaction , 2012, Front. Immun..

[109]  M. Tsai,et al.  IgE and mast cells in allergic disease , 2012, Nature Medicine.

[110]  S. Hartmann,et al.  Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines , 2012, Proceedings of the National Academy of Sciences.

[111]  D. Sheppard,et al.  The Role of Mast Cells in the Defence against Pathogens , 2012, PLoS pathogens.

[112]  K. Ravid,et al.  Mast Cell Adenosine Receptors Function: A Focus on the A3 Adenosine Receptor and Inflammation , 2012, Front. Immun..

[113]  M. Matho,et al.  Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy. , 2012, The Journal of clinical investigation.

[114]  P. Hwu,et al.  Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal Adenocarcinoma , 2011, Clinical Cancer Research.

[115]  G. Nilsson,et al.  Mast cells as regulators of skin inflammation and immunity. , 2011, Acta dermato-venereologica.

[116]  G. Nilsson,et al.  Mast cells generated from patients with atopic eczema have enhanced levels of granule mediators and an impaired Dectin‐1 expression , 2011, Allergy.

[117]  M. Santoro,et al.  Mast cells have a protumorigenic role in human thyroid cancer , 2010, Oncogene.

[118]  Robert Anderson,et al.  Dengue Virus Infection of Mast Cells Triggers Endothelial Cell Activation , 2010, Journal of Virology.

[119]  S. Abraham,et al.  Role of Mast Cells in Inflammatory Bowel Disease and Inflammation-Associated Colorectal Neoplasia in IL-10-Deficient Mice , 2010, PloS one.

[120]  Gunnar Pejler,et al.  Mast cell proteases: multifaceted regulators of inflammatory disease. , 2010, Blood.

[121]  S. Abraham,et al.  Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.

[122]  L. Hartmann,et al.  Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. , 2010, Cancer research.

[123]  R. Liblau,et al.  Cell-cell cooperation at the T helper cell/mast cell immunological synapse. , 2009, Blood.

[124]  B. Guss,et al.  Infection of Mast Cells with Live Streptococci Causes a Toll-Like Receptor 2- and Cell-Cell Contact-Dependent Cytokine and Chemokine Response , 2009, Infection and Immunity.

[125]  C. Kunder,et al.  Mast cell–derived particles deliver peripheral signals to remote lymph nodes , 2009, The Journal of experimental medicine.

[126]  D. Metcalfe,et al.  Mechanisms of mast cell signaling in anaphylaxis. , 2009, The Journal of allergy and clinical immunology.

[127]  W. Sippl,et al.  Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT , 2009, PloS one.

[128]  I. Brodsky,et al.  NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. , 2009, Seminars in immunology.

[129]  T. Vlaykova,et al.  Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer , 2009, Journal of gastroenterology and hepatology.

[130]  G. Sauter,et al.  Immunological microenvironment in prostate cancer: High mast cell densities are associated with favorable tumor characteristics and good prognosis , 2009, The Prostate.

[131]  G. Nilsson,et al.  TLR2/MyD88-Dependent and -Independent Activation of Mast Cell IgE Responses by the Skin Commensal Yeast Malassezia sympodialis1 , 2009, The Journal of Immunology.

[132]  G. Alí,et al.  Tryptase Mast Cells in Malignant Pleural Mesothelioma as an Independent Favorable Prognostic Factor , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[133]  A. Zychlinsky,et al.  Mouse Neutrophil Extracellular Traps in Microbial Infections , 2009, Journal of Innate Immunity.

[134]  F. Sinicrope,et al.  BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells , 2009, Clinical Cancer Research.

[135]  G. Hutchins,et al.  Nf1-Dependent Tumors Require a Microenvironment Containing Nf1 +/−- and c-kit-Dependent Bone Marrow , 2008, Cell.

[136]  Stephen J. Galli,et al.  The development of allergic inflammation , 2008, Nature.

[137]  M. Tsai,et al.  Immunomodulatory mast cells: negative, as well as positive, regulators of immunity , 2008, Nature Reviews Immunology.

[138]  K. Yamauchi,et al.  Progress in allergy signal research on mast cells: the role of histamine in goblet cell hyperplasia in allergic airway inflammation - a study using the Hdc knockout mouse. , 2008, Journal of pharmacological sciences.

[139]  C. Mackay,et al.  Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2 , 2008, Immunology and cell biology.

[140]  M. Metintaş,et al.  The Significance and Relationship between Mast Cells and Tumour Angiogenesis in Non-small Cell Lung Carcinoma , 2008, The Journal of international medical research.

[141]  M. D. de Lutiis,et al.  Role of mast cells in tumor growth. , 2007, Annals of clinical and laboratory science.

[142]  K. Aozasa,et al.  Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer , 2007, British Journal of Cancer.

[143]  I. Bachelet,et al.  Mast cells as effector cells: a co-stimulating question. , 2007, Trends in immunology.

[144]  D. Jäger,et al.  Intratumoural injection of the toll-like receptor-2/6 agonist ‘macrophage-activating lipopeptide-2’ in patients with pancreatic carcinoma: a phase I/II trial , 2007, British Journal of Cancer.

[145]  R. Adachi,et al.  Mast Cell-restricted Tryptases: Structure and Function in Inflammation and Pathogen Defense* , 2007, Journal of Biological Chemistry.

[146]  G. Caughey Mast cell tryptases and chymases in inflammation and host defense , 2007, Immunological reviews.

[147]  R. Sagi-Eisenberg The mast cell: where endocytosis and regulated exocytosis meet , 2007, Immunological reviews.

[148]  M. Maurer,et al.  Skin mast cells control T cell‐dependent host defense in Leishmania major infections , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[149]  S. Mäkinen‐Kiljunen,et al.  Clustered sensitivity to fungi: anaphylactic reactions caused by ingestive allergy to yeasts. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[150]  L. Hellman,et al.  Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution , 2006, Immunogenetics.

[151]  J. Mestan,et al.  AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL , 2006, British Journal of Cancer.

[152]  F. Brennan,et al.  Bruton’s Tyrosine Kinase Is Required for TLR2 and TLR4-Induced TNF, but Not IL-6, Production1 , 2006, The Journal of Immunology.

[153]  D. McDonald,et al.  Mast cells protect mice from Mycoplasma pneumonia. , 2006, American journal of respiratory and critical care medicine.

[154]  G. Nilsson,et al.  Angiogenesis and mast cells in Hodgkin lymphoma , 2005, Leukemia.

[155]  H. Sudhoff,et al.  Role of mast cells in otitis media. , 2005, The Journal of allergy and clinical immunology.

[156]  P. Disaia,et al.  Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. , 2005, Gynecologic oncology.

[157]  C. Cetrulo,et al.  Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells , 2005, British journal of pharmacology.

[158]  J. Wedemeyer,et al.  Decreased susceptibility of mast cell-deficient KitW/KitW-v mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors , 2005, Laboratory Investigation.

[159]  Zhi-xiang Shen,et al.  Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. , 2005, World journal of gastroenterology.

[160]  J. Norgauer,et al.  H1 histamine receptor mediates inflammatory responses in human keratinocytes. , 2004, The Journal of allergy and clinical immunology.

[161]  A. Brill,et al.  Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[162]  H. Matsue,et al.  The effects of endothelin‐1 on degranulation, cytokine, and growth factor production by skin‐derived mast cells , 2004, European journal of immunology.

[163]  P. Conti,et al.  Mast cells: the Jekyll and Hyde of tumor growth. , 2004, Trends in immunology.

[164]  F. Villinger,et al.  Signaling through Toll-Like Receptors Triggers HIV-1 Replication in Latently Infected Mast Cells1 , 2004, The Journal of Immunology.

[165]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[166]  G. W. Wong,et al.  Mouse Chromosome 17A3.3 Contains 13 Genes That Encode Functional Tryptic-like Serine Proteases with Distinct Tissue and Cell Expression Patterns* , 2004, Journal of Biological Chemistry.

[167]  M. Samoszuk,et al.  Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer , 2003, International journal of cancer.

[168]  R. Hernández-Pando,et al.  Mast Cell Activation by Mycobacterium tuberculosis: Mediator Release and Role of CD48 1 , 2003, The Journal of Immunology.

[169]  H. Okabe,et al.  Gabexate Mesilate, a Synthetic Protease Inhibitor, Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Inhibiting Activation of Both Nuclear Factor-κB and Activator Protein-1 in Human Monocytes , 2003, Journal of Pharmacology and Experimental Therapeutics.

[170]  I. Biaggioni,et al.  Mast Cell–Mediated Stimulation of Angiogenesis: Cooperative Interaction Between A2B and A3 Adenosine Receptors , 2003, Circulation research.

[171]  L. Björck,et al.  Immunoglobulin Superantigen Protein L Induces IL-4 and IL-13 Secretion from Human FcεRI+ Cells Through Interaction with the κ Light Chains of IgE 1 , 2003, The Journal of Immunology.

[172]  Nathan Chandler,et al.  Corticotropin-Releasing Hormone and Brain Mast Cells Regulate Blood-Brain-Barrier Permeability Induced by Acute Stress , 2002, Journal of Pharmacology and Experimental Therapeutics.

[173]  V. Meineke,et al.  Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: Possible relevance to human fibrotic disorders , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[174]  M. Papich Saunders Handbook of Veterinary Drugs , 2002 .

[175]  A. Demircan,et al.  The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. , 2001, Journal of clinical pathology.

[176]  J. Cherrington,et al.  The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. , 2001, Blood.

[177]  C. Lawrence,et al.  Delayed Expulsion of the Nematode Trichinella spiralisIn Mice Lacking the Mucosal Mast Cell–Specific Granule Chymase, Mouse Mast Cell Protease-1 , 2000, The Journal of experimental medicine.

[178]  S. Jimi,et al.  Increased Density of Interstitial Mast Cells in Amyloid A Renal Amyloidosis , 2000, Modern Pathology.

[179]  S. Jimi,et al.  Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. , 2000, Human pathology.

[180]  T. Kudo,et al.  Nafamostat mesilate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apoptosis in cultured human trophoblasts. , 2000, Life sciences.

[181]  P. Cui,et al.  Chymase is a potent chemoattractant for human monocytes and neutrophils , 2000, Journal of leukocyte biology.

[182]  K. Manova,et al.  Point mutation in Kit receptor tyrosine kinase reveals essential roles for Kit signaling in spermatogenesis and oogenesis without affecting other Kit responses , 2000, The EMBO journal.

[183]  K. Tryggvason,et al.  The macrophage receptor MARCO. , 2000, Microbes and infection.

[184]  J. Kinet,et al.  Signalling through the high-affinity IgE receptor FcεRI , 1999, Nature.

[185]  T. Kawakami,et al.  Functions of Bruton's tyrosine kinase in mast and B cells , 1999, Journal of leukocyte biology.

[186]  M. Stack,et al.  Proteinase requirements of epidermal growth factor–induced ovarian cancer cell invasion , 1998, International journal of cancer.

[187]  P. Arvan,et al.  Sorting and storage during secretory granule biogenesis: looking backward and looking forward. , 1998, The Biochemical journal.

[188]  Michael Loran Dustin,et al.  Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic , 1997, Nature.

[189]  S. Ren,et al.  Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. , 1997, The Journal of clinical investigation.

[190]  D. Friend,et al.  Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype , 1996, The Journal of cell biology.

[191]  R. Edwards,et al.  Transport of histamine by vesicular monoamine transporter-2 , 1995, Neuropharmacology.

[192]  B. Dewald,et al.  Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytes , 1995 .

[193]  I. Taşdemir,et al.  Intestinal protection against Strongyloides ratti and mastocytosis induced by administration of interleukin-3 in mice. , 1993, Immunology.

[194]  Y. Horii,et al.  Mucosal mast cells and the expulsive mechanisms of mice against Strongyloides venezuelensis. , 1993, International journal for parasitology.

[195]  R. D. Hanson,et al.  The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. , 1993, Genomics.

[196]  H. Kelly,et al.  Cromolyn Sodium: A Review of Mechanisms and Clinical Use in Asthma , 1987, Drug intelligence & clinical pharmacy.

[197]  H. Müller-Eberhard,et al.  Release of histamine from rat mast cells by the complement peptides C3a and C5a. , 1975, Immunology.

[198]  G. Asboe-hansen Mast cells in health and disease. , 1968, Bulletin of the New York Academy of Medicine.

[199]  W. Gong,et al.  The Critical Role of the Antimicrobial Peptide LL-37/ CRAMP in Protection of Colon Microbiota Balance, Mucosal Homeostasis, Anti-Inflammatory Responses, and Resistance to Carcinogenesis. , 2019, Critical reviews in immunology.

[200]  Joakim S. Dahlin,et al.  Mast cell progenitors: origin, development and migration to tissues. , 2015, Molecular immunology.

[201]  N. Hogg,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Mast cell and macrophage chemokines CXCL 1 / CXCL 2 control the early stage of neutrophil recruitment during tissue in fl ammation , 2013 .

[202]  R. Benezra,et al.  Chapter Fifteen – Targeting Protein–Protein Interactions to Treat Cancer—Recent Progress and Future Directions , 2013 .

[203]  K. Amin The role of mast cells in allergic inflammation. , 2012, Respiratory medicine.

[204]  M. E. Walker,et al.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? , 2012, Biochimica et biophysica acta.

[205]  M. Tsai,et al.  Mast cells and immunoregulation/immunomodulation. , 2011, Advances in experimental medicine and biology.

[206]  G. Caughey Mast cell proteases as protective and inflammatory mediators. , 2011, Advances in experimental medicine and biology.

[207]  A. Sica,et al.  Tumor promotion by tumor-associated macrophages. , 2007, Advances in experimental medicine and biology.

[208]  S. Ch’ng,et al.  Mast cells and cutaneous malignancies , 2006, Modern Pathology.

[209]  E. Voest,et al.  TUMOR VASCULATURE AS A TARGET , 2002 .

[210]  R. Kokenyesi Ovarian carcinoma cells synthesize both chondroitin sulfate and heparan sulfate cell surface proteoglycans that mediate cell adhesion to interstitial matrix , 2001, Journal of cellular biochemistry.

[211]  F. Levi-Schaffer,et al.  Mast cells and fibroblasts: two interacting cells , 1994, International journal of clinical & laboratory research.

[212]  G. Pinkus,et al.  Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology , 2022 .